Beneficial haemodynamic and renal sodium handling effects of combined midodrine and octreotide treatment in a cirrhotic patient with large hepatic hydrothorax and mild ascites [7]

Nephrology Dialysis Transplantation

Volumn 20, Issue 11, 2005, Pages 2583-

  Kalambokis, Georgios ^a   Fotopoulos, Andreas ^a   Economou, Michael ^a   Tsianos, Epameinondas V ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CREATININE; FUROSEMIDE; GLUCAGON; MIDODRINE; OCTREOTIDE; PENTETATE TECHNETIUM TC 99M; SODIUM; SPIRONOLACTONE; UREA; VASOPRESSIN;

AGED; ALDOSTERONE BLOOD LEVEL; ASCITES; BRAIN DISEASE; CASE REPORT; CREATININE BLOOD LEVEL; DEATH; DISEASE SEVERITY; DRUG INDUCED DISEASE; DYSPNEA; FEMALE; GLOMERULUS FILTRATION RATE; GLUCAGON BLOOD LEVEL; HEART OUTPUT; HEMODYNAMICS; HEPATITIS C VIRUS; HUMAN; HYDROTHORAX; HYPONATREMIA; KIDNEY PLASMA FLOW; LETTER; LIVER CIRRHOSIS; LIVER DISEASE; MEAN ARTERIAL PRESSURE; NONHUMAN; PARACENTESIS; PLASMA RENIN ACTIVITY; PLEURA EFFUSION; PRIORITY JOURNAL; SODIUM URINE LEVEL; UREA BLOOD LEVEL; VASOPRESSIN BLOOD LEVEL;

ADRENERGIC ALPHA-AGONISTS; AGED; ASCITES; DRUG THERAPY, COMBINATION; FEMALE; GASTROINTESTINAL AGENTS; HEMODYNAMIC PROCESSES; HUMANS; HYDROTHORAX; LIVER CIRRHOSIS; MIDODRINE; OCTREOTIDE; SODIUM;

EID: 27644592010     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi055     Document Type: Letter

References (5)

1. Lazaridis KN, Frank JW, Krowka MJ, Kamath PS. Hepatic hydrothorax: pathogenesis, diagnosis and management. Am J Med 1999; 107: 262-267
2. Dumortier J, Leprêtre J, Scalone O et al. Successful treatment of hepatic hydrothorax with octreotide. Eur J Gastroenterol Hepatol 2000; 12: 817-820
3. Pfammater R, Quatropani C, Reichen J, Goke B, Wagner AC. Treatment of hepatic hydrothorax and reduction of chest tube output with octreotide. Eur J Gastroenterol Hepatol 2001; 13: 977-980
4. Kalambokis G, Economou M, Fotopoulos A et al. The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites. Am J Gastroenterol 2005; 100: 879-885
5. Wiest R, Tsai MH, Groszmann RJ. Octreotide potentiates PKC-dependent vasoconstrictors in portal hypertensive and control rats. Gastroenterology 2001; 120: 975-983